Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. Felbinac - Wikipedia
Felbinac - Wikipedia
From Wikipedia, the free encyclopedia
Topical NSAID medication
Pharmaceutical compound
Felbinac
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Topical
ATC code
  • M02AA08 (WHO)
Legal status
Legal status
  • UK: P (Pharmacy medicines)
Identifiers
IUPAC name
  • biphenyl-4-ylacetic acid
CAS Number
  • 5728-52-9
PubChem CID
  • 3332
DrugBank
  • DB07477 checkY
ChemSpider
  • 3215 checkY
UNII
  • 94WNJ5U8L7
KEGG
  • D01675 checkY
ChEBI
  • CHEBI:31597 checkY
ChEMBL
  • ChEMBL413965 checkY
CompTox Dashboard (EPA)
  • DTXSID0045389 Edit this at Wikidata
ECHA InfoCard100.024.758 Edit this at Wikidata
Chemical and physical data
FormulaC14H12O2
Molar mass212.248 g·mol−1
3D model (JSmol)
  • Interactive image
SMILES
  • O=C(O)Cc1ccc(cc1)c2ccccc2
InChI
  • InChI=1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16) checkY
  • Key:QRZAKQDHEVVFRX-UHFFFAOYSA-N checkY
  (verify)

Felbinac (INN, or biphenylylacetic acid) is a topical medicine,[1] belonging to the family of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs) of the arylacetic acid (not arylpropionic acid) class, which is used to treat muscle inflammation and arthritis.[2] It is an active metabolite of fenbufen.[3]

Related compounds

[edit]

The α-methyl acid of felbinac is called biprofen and is used to prepare bifepramide. The α-ethyl acid is called xenbucin which is used to make xenthiorate.

See also

[edit]
  • Fluenetil

References

[edit]
  1. ^ The Merck Index, 12th Edition. 3989
  2. ^ Description of Felbinac on Tiscali [1]
  3. ^ Kohler C, Tolman E, Wooding W, Ellenbogen L (1980). "A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function". Arzneimittelforschung. 30 (4A): 702–707. PMID 6254545.
  • v
  • t
  • e
Nonsteroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)
pyrazolones /
pyrazolidines
  • Aminophenazone
  • Ampyrone
  • Azapropazone
  • Clofezone
  • Difenamizole
  • Famprofazone
  • Feprazone
  • Kebuzone
  • Metamizole
  • Mofebutazone
  • Morazone
  • Nifenazone
  • Oxyphenbutazone
  • Phenazone
  • Phenylbutazone
  • Propyphenazone
  • Sulfinpyrazone
  • Suxibuzone‡
salicylates
  • Aspirin (acetylsalicylic acid)#
  • Aloxiprin
  • Benorylate
  • Carbasalate calcium
  • Diflunisal
  • Dipyrocetyl
  • Ethenzamide
  • Guacetisal
  • Magnesium salicylate
  • Methyl salicylate
  • Salsalate
  • Salicin
  • Salicylamide
  • Salicylic acid (salicylate)
  • Sodium salicylate
acetic acid derivatives
and related substances
  • Aceclofenac
  • Acemetacin
  • Alclofenac
  • Amfenac
  • Bendazac
  • Bromfenac
  • Bufexamac
  • Bumadizone
  • Diclofenac
  • Difenpiramide
  • Etodolac
  • Felbinac
  • Fenclozic acid
  • Fentiazac
  • Indometacin
  • Indometacin farnesil
  • Isoxepac
  • Ketorolac
  • Lonazolac
  • Mofezolac
  • Oxametacin
  • Prodolic acid
  • Proglumetacin
  • Sulindac
  • Tiopinac
  • Tolmetin
  • Zomepirac†
oxicams
  • Ampiroxicam
  • Droxicam
  • Isoxicam
  • Lornoxicam
  • Meloxicam
  • Piroxicam
  • Pivoxicam
  • Tenoxicam
propionic acid
derivatives (profens)
  • Alminoprofen
  • Benoxaprofen†
  • Carprofen‡
  • Dexibuprofen
  • Dexketoprofen
  • Fenbufen
  • Fenoprofen
  • Flunoxaprofen
  • Flurbiprofen
  • Ibuprofen#
  • Ibuproxam
  • Indoprofen†
  • Ketoprofen
  • Loxoprofen
  • Miroprofen
  • Naproxen
  • Oxaprozin
  • Pelubiprofen
  • Piketoprofen
  • Pirprofen
  • Suprofen
  • Tarenflurbil
  • Tepoxalin‡
  • Tiaprofenic acid
  • Vedaprofen‡
  • Zaltoprofen
  • COX-inhibiting nitric oxide donator: Naproxcinod
n-arylanthranilic
acids (fenamates)
  • Azapropazone
  • Clonixin
  • Etofenamate
  • Floctafenine
  • Flufenamic acid
  • Flunixin
  • Flutiazin
  • Glafenine†
  • Meclofenamic acid
  • Mefenamic acid
  • Morniflumate
  • Niflumic acid
  • Tolfenamic acid
COX-2 inhibitors
(coxibs)
  • Apricoxib
  • Celecoxib (+tramadol)
  • Cimicoxib‡
  • Deracoxib‡
  • Etoricoxib
  • Firocoxib‡
  • Lumiracoxib†
  • Mavacoxib‡
  • Parecoxib
  • Robenacoxib‡
  • Rofecoxib†
  • Valdecoxib†
other
  • Aminopropionitrile
  • Benzydamine
  • Chondroitin sulfate
  • Diacerein
  • Fluproquazone
  • Glucosamine
  • Glycosaminoglycan
  • Grapiprant‡
  • Hyperforin
  • Nabumetone
  • Nimesulide
  • Oxaceprol
  • Proquazone
  • Superoxide dismutase / orgotein
  • Tenidap
NSAID
combinations
  • Ibuprofen/famotidine
  • Ibuprofen/hydrocodone
  • Ibuprofen/oxycodone
  • Ibuprofen/paracetamol
  • Meloxicam/bupivacaine
  • Meloxicam/rizatriptan
  • Naproxen/diphenhydramine
  • Naproxen/esomeprazole
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use.
  • category
  • commons
  • portal
  • v
  • t
  • e
Topical products for joint and muscular pain (M02)
Anti-inflammatory
preparations,
non-steroids
Pyrazolidines
  • Clofezone
  • Mofebutazone
  • Oxyphenbutazone
  • Phenylbutazone
Acetic acid
derivatives
  • Diclofenac
  • Fentiazac
  • Tolmetin
Other
  • Bendazac
  • Benzydamine
  • Bufexamac
  • Etofenamate
  • Felbinac
  • Feprazone
  • Flurbiprofen
  • Ibuprofen
  • Indometacin
  • Ketoprofen
  • Meclofenamic acid
  • Naproxen
  • Nifenazone
  • Niflumic acid
  • Piketoprofen
  • Piroxicam
  • Suxibuzone
Capsaicin derivatives
  • Zucapsaicin
Other
  • Dimethyl sulfoxide
  • Idrocilamide
  • Tolazoline
  • v
  • t
  • e
Prostanoid signaling modulators
Receptor
(ligands)
DP (D2)Tooltip Prostaglandin D2 receptor
DP1Tooltip Prostaglandin D2 receptor 1
  • Agonists: Prostaglandin D2
  • Treprostinil
  • Antagonists: Asapiprant
  • Laropiprant
  • Vidupiprant
DP2Tooltip Prostaglandin D2 receptor 2
  • Agonists: Indometacin
  • Prostaglandin D2
  • Antagonists: ADC-3680
  • AZD-1981
  • Bay U3405
  • Fevipiprant
  • MK-1029
  • MK-7246
  • QAV-680
  • Ramatroban
  • Setipiprant
  • Timapiprant
  • TM30089
  • Vidupiprant
EP (E2)Tooltip Prostaglandin E2 receptor
EP1Tooltip Prostaglandin EP1 receptor
  • Agonists: Beraprost
  • Enprostil
  • Iloprost (ciloprost)
  • Latanoprost
  • Lubiprostone
  • Misoprostol
  • Prostaglandin E1 (alprostadil)
  • Prostaglandin E2 (dinoprostone)
  • Sulprostone
  • Antagonists: AH-6809
  • ONO-8130
  • SC-19220
  • SC-51089
  • SC-51322
EP2Tooltip Prostaglandin EP2 receptor
  • Agonists: Butaprost
  • Misoprostol
  • Prostaglandin E1 (alprostadil)
  • Prostaglandin E2 (dinoprostone)
  • Treprostinil
  • Antagonists: AH-6809
  • PF-04418948
  • TG 4-155
EP3Tooltip Prostaglandin EP3 receptor
  • Agonists: Beraprost
  • Carbacyclin
  • Cicaprost
  • Enprostil
  • Iloprost (ciloprost)
  • Isocarbacyclin
  • Latanoprost
  • Misoprostol
  • Prostaglandin D2
  • Prostaglandin E1 (alprostadil)
  • Prostaglandin E2 (dinoprostone)
  • Remiprostol
  • Ricinoleic acid
  • Sulprostone
  • Antagonists: L-798106
EP4Tooltip Prostaglandin EP4 receptor
  • Agonists: Lubiprostone
  • Misoprostol
  • Prostaglandin E1 (alprostadil)
  • Prostaglandin E2 (dinoprostone)
  • TCS-2510
  • Antagonists: Grapiprant
  • GW-627368
  • L-161982
  • ONO-AE3-208
Unsorted
  • Agonists: 16,16-Dimethyl Prostaglandin E2
  • Aganepag
  • Carboprost
  • Evatanepag
  • Gemeprost
  • Nocloprost
  • Omidenepag
  • Prostaglandin F2α (dinoprost)
  • Simenepag
  • Taprenepag
FP (F2α)Tooltip Prostaglandin F receptor
  • Agonists: Alfaprostol
  • Bimatoprost
  • Carboprost
  • Cloprostenol
  • Enprostil
  • Fluprostenol
  • Latanoprost
  • Prostaglandin D2
  • Prostaglandin F2α (dinoprost)
  • Sulotroban
  • Tafluprost
  • Travoprost
  • Unoprostone
IP (I2)Tooltip Prostacyclin receptor
  • Agonists: ACT-333679
  • AFP-07
  • Beraprost
  • BMY-45778
  • Carbacyclin
  • Cicaprost
  • Iloprost (ciloprost)
  • Isocarbacyclin
  • MRE-269
  • NS-304
  • Prostacyclin (prostaglandin I2, epoprostenol)
  • Prostaglandin E1 (alprostadil)
  • Ralinepag
  • Selexipag
  • Taprostene
  • TRA-418
  • Treprostinil
  • Antagonists: RO1138452
TP (TXA2)Tooltip Thromboxane receptor
  • Agonists: Carbocyclic thromboxane A2
  • I-BOP
  • Thromboxane A2
  • U-46619
  • Vapiprost
  • Antagonists: 12-HETE
  • 13-APA
  • AA-2414
  • Argatroban
  • Bay U3405
  • BMS-180,291
  • Daltroban
  • Domitroban
  • EP-045
  • GR-32191
  • ICI-185282
  • ICI-192605
  • Ifetroban
  • Imitrodast
  • L-655240
  • L-670596
  • Linotroban
  • Mipitroban
  • ONO-3708
  • ONO-11120
  • Picotamide
  • Pinane thromboxane A2
  • Ramatroban
  • Ridogrel
  • S-145
  • Samixogrel
  • Seratrodast
  • SQ-28,668
  • SQ-29,548
  • Sulotroban
  • Terbogrel
  • Terutroban
  • TRA-418
Unsorted
  • Arbaprostil
  • Ataprost
  • Ciprostene
  • Clinprost
  • Cobiprostone
  • Delprostenate
  • Deprostil
  • Dimoxaprost
  • Doxaprost
  • Ecraprost
  • Eganoprost
  • Enisoprost
  • Eptaloprost
  • Esuberaprost
  • Etiproston
  • Fenprostalene
  • Flunoprost
  • Froxiprost
  • Lanproston
  • Limaprost
  • Luprostiol
  • Meteneprost
  • Mexiprostil
  • Naxaprostene
  • Nileprost
  • Nocloprost
  • Ornoprostil
  • Oxoprostol
  • Penprostene
  • Pimilprost
  • Piriprost
  • Posaraprost
  • Prostalene
  • Rioprostil
  • Rivenprost
  • Rosaprostol
  • Spiriprostil
  • Tiaprost
  • Tilsuprost
  • Tiprostanide
  • Trimoprostil
  • Viprostol
Enzyme
(inhibitors)
COX
(PTGS)
  • Salicylic acids: Aloxiprin
  • Aspirin (acetylsalicylic acid)
  • Benorilate (benorylate)
  • Carbasalate calcium
  • Diflunisal
  • Dipyrocetyl
  • Ethenzamide
  • Guacetisal
  • Magnesium salicylate
  • Mesalazine (5-aminosalicylic acid)
  • Methyl salicylate
  • Salacetamide
  • Salicin
  • Salicylamide
  • Salicylate (salicylic acid)
  • Salsalate
  • Sodium salicylate
  • Triflusal; Acetic acids: Aceclofenac
  • Acemetacin
  • Aclofenac
  • Amfenac
  • Alclofenac
  • Bendazac
  • Bromfenac
  • Bufexamac
  • Bumadizone
  • Cinmetacin
  • Clometacin
  • Diclofenac
  • Difenpiramide
  • Etodolac
  • Felbinac
  • Fenclofenac
  • Fentiazac
  • Glucametacin
  • Indometacin (indomethacin)
  • Indometacin farnesil
  • Ketorolac
  • Lonazolac
  • Mofezolac
  • Nabumetone
  • Oxametacin
  • Oxindanac
  • Proglumetacin
  • Sulindac
  • Sulindac sulfide
  • Tolmetin
  • Zidometacin
  • Zomepirac; Propionic acids: Alminoprofen
  • Benoxaprofen
  • Bucloxic acid (blucloxate)
  • Butibufen
  • Carprofen
  • Dexibuprofen
  • Dexindoprofen
  • Dexketoprofen
  • Fenbufen
  • Fenoprofen
  • Flunoxaprofen
  • Flurbiprofen
  • Ibuprofen
  • Ibuproxam
  • Indoprofen
  • Ketoprofen
  • Loxoprofen
  • Miroprofen
  • Naproxen
  • Naproxcinod
  • Oxaprozin
  • Pirprofen
  • Pranoprofen
  • Suprofen
  • Tarenflurbil
  • Tepoxalin
  • Tiaprofenic acid (tiaprofenate)
  • Vedaprofen; Anthranilic acids (fenamic acids): Etofenamic acid (etofenamate)
  • Floctafenic acid (floctafenate)
  • Flufenamic acid (flufenamate)
  • Meclofenamic acid (meclofenamate)
  • Mefenamic acid (mefenamate)
  • Morniflumic acid (morniflumate)
  • Niflumic acid (niflumate)
  • Talinflumic acid (talinflumate)
  • Tolfenamic acid (tolfenamate); Pyrazolones: Azapropazone
  • Dipyrone
  • Isopyrin
  • Oxyphenbutazone
  • Phenylbutazone; Enolic acids (oxicams): Ampiroxicam
  • Droxicam
  • Enolicam
  • Isoxicam
  • Lornoxicam
  • Meloxicam
  • Piroxicam
  • Tenoxicam; 4-Aminoquinolines: Antrafenine
  • Floctafenine
  • Glafenine; Quinazolines: Fluproquazone
  • Proquazone; Aminonicotinic acids: Clonixeril
  • Clonixin
  • Flunixin; Sulfonanilides: Flosulide
  • Nimesulide; Aminophenols (anilines): Acetanilide
  • AM-404 (N-arachidonoylaminophenol)
  • Bucetin
  • Paracetamol (acetaminophen)
  • Parapropamol
  • Phenacetin
  • Propacetamol; Selective COX-2 inhibitors (coxibs): Apricoxib
  • Celecoxib
  • Cimicoxib
  • Deracoxib
  • Etoricoxib
  • Firocoxib
  • Lumiracoxib
  • Mavacoxib
  • Parecoxib
  • Polmacoxib
  • Robenacoxib
  • Rofecoxib
  • Tilmacoxib
  • Valdecoxib; Others/unsorted: Anitrazafen
  • Clobuzarit
  • Curcumin
  • DuP-697
  • FK-3311
  • Flumizole
  • FR-122047
  • Glimepiride
  • Hyperforin
  • Itazigrel
  • L-655240
  • L-670596
  • Licofelone
  • Menatetrenone (vitamin K2)
  • NCX-466
  • NCX-4040
  • NS-398
  • Pamicogrel
  • Resveratrol
  • Romazarit
  • Rosmarinic acid
  • Rutecarpine
  • Satigrel
  • SC-236
  • SC-560
  • SC-58125
  • Tenidap
  • Tiflamizole
  • Timegadine
  • Trifenagrel
  • Tropesin
PGD2STooltip Prostaglandin D synthase
  • Retinoids
  • Selenium (selenium tetrachloride, sodium selenite, selenium disulfide)
PGESTooltip Prostaglandin E synthase
HQL-79
PGFSTooltip Prostaglandin F synthase
Bimatoprost
PGI2STooltip Prostacyclin synthase
Tranylcypromine
TXASTooltip Thromboxane A synthase
  • Camonagrel
  • Dazmegrel
  • Dazoxiben
  • Furegrelate
  • Isbogrel
  • Midazogrel
  • Nafagrel
  • Nicogrelate
  • Ozagrel
  • Picotamide
  • Pirmagrel
  • Ridogrel
  • Rolafagrel
  • Samixogrel
  • Terbogrel
  • U63557A
Others
  • Precursors: Linoleic acid
  • γ-Linolenic acid (gamolenic acid)
  • Dihomo-γ-linolenic acid
  • Diacylglycerol
  • Arachidonic acid
  • Prostaglandin G2
  • Prostaglandin H2
See also
Receptor/signaling modulators
Leukotriene signaling modulators


Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://teknopedia.ac.id/w/index.php?title=Felbinac&oldid=1268659924"
Categories:
  • Nonsteroidal anti-inflammatory drugs
  • Musculoskeletal system drug stubs
Hidden categories:
  • Articles with short description
  • Short description is different from Wikidata
  • ECHA InfoCard ID from Wikidata
  • Drugboxes which contain changes to watched fields
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id